Thank you for your participation!
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115
About the Conference
The First Stop for Growing Your
The 15th Annual Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2016 Trans-Pacific Health Sciences Dialogue!
Industry News from FiercePharmaAsia
- India's Piramal investing $55M in API productionIndian CDMO Piramal Pharma Solutions is beefing up its global API production, including in the U.S., where it has expanded in recent years.
- Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRLThe FDA, which had already criticized the plant where Biocon is producing biosimilars for the U.S. market, has now issued it and partner Mylan a complete response letter tied to manufacturing for one of them.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.